(9/11/15) By Alan D. D’Andrea, MD, Dana-Farber Cancer Institute and Harvard Medical School, and Elizabeth M. Swisher, MD, University of Washington September is Ovarian Cancer Awareness Month, when we scientists … Continued
The largest private funder of ovarian cancer research awarded $6.3 million in grants while also launching new events and partnerships (September 11, 2015) –Ovarian Cancer Research Fund (OCRF), has awarded … Continued
Ovarian Cancer Research Fund’s Luxury Shopping Event to be held at Grand Canal Shoppes at The Venetian & The Palazzo and Fashion Show, September 19-20 Las Vegas, NV – Ovarian … Continued
(August 26, 2015) Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a … Continued
(August 19, 2015) Whereas chemotherapy kills cancer cells only while it is being administered, immunotherapy can lead to an adaptive immune response that persists long after treatment is ceased. By … Continued
On August 3, 2015 the New York Times published an article about the use of IP chemotherapy in the treatment of ovarian cancer. Our CEO, Calaneet Balas joined with Ovarian Cancer Research Fund CEO, Audra Moran, to write a response to the New York Times. Click the plus sign to see their Letter to the Editor.
(8/12/15) In response to the article “An Ovarian Cancer Treatment, Recommended Since 2006, is Found to be Underused,“ published in the Health section of The New York Times on August 3, 2015, OCRF … Continued
Gynecologic Cancer Patients to Receive Support in 6 New Locations WEST CHESTER, Pa (August 10, 2015) —Ovarian Cancer Research Fund (OCRF) and QVC today announced six new Woman to Woman … Continued
(July 30, 2015) Recurrent ovarian cancer patients have more hope today, thanks to OCRF-funded research by David Pepin, PhD at Massachusetts General Hospital. Dr. Pepin and his colleagues found that … Continued
(July 23, 2015) New OCRF-funded research demonstrates that combining a PARP-inhibitor with immune therapy results in tumor rejection and long-term survival in a mouse model of BRCA1-deficient ovarian cancer. The … Continued
QVC and Ovarian Cancer Research Fund Joining Forces for “QVC Presents Super Saturday LIVE” Broadcast WEST CHESTER, Pa. (July 21, 2015) – Help advance the fight against ovarian cancer with … Continued
NASCAR’s Martin Truex Jr.’s girlfriend Sherry Pollex goes to Capitol Hill to advocate for affordable therapy costs, ovarian cancer research funding Pollex, Ovarian Cancer National Alliance support Cancer Treatment Parity … Continued
Get email updates about research news, action alerts, and ways to join the fight.
